Browse our collection
This first in human phase 1 study evaluated CARv3 TEAM E T cells engineered to …
A 47 year old man presented with fever and weakness, later diagnosed with acute promyelocytic …
This perspective article explores how medically tailored meals can mitigate the health impacts of food …
This case series evaluates the safety and efficacy of CD19 CAR T-cell therapy in 15 …
his letter reports extended efficacy data from the phase 3 RENOIR trial evaluating the bivalent …
A 38-year-old man with a history of kidney transplantation presented with a 2-week history of …
This correspondence documents the transcontinental spread of a highly drug-resistant seventh-pandemic Vibrio cholerae O1 El …
This phase 3a, double-blind, randomized, placebo-controlled trial evaluated the efficacy and safety of once-weekly cagrilintide …
This editorial discusses the transformative potential of gene therapies like exagamglogene autotemcel (exa-cel) and lovotibeglogene …
This correspondence highlights how selpercatinib, a RET kinase inhibitor used in RET altered lung and …
A 70-year-old man with rheumatoid arthritis and immunosuppressive therapy presented with a 7-day history …
This editorial discusses the evolving surgical standards in gynecologic oncology, particularly the shift from radical …
This editorial explores a novel strategy combining CD7 targeted CAR T-cell therapy with allogeneic hematopoietic …
This correspondence evaluates the offtarget editing risk of exagamglogene autotemcel (exa cel), a CRISPR Cas9 …
Unemployment among graduates of tertiary institutions in Nigeria has remained a persistent socio-economic challenge, often …
This editorial discusses the evolution and effectiveness of noninvasive colorectal cancer screening methods, including guaiac …
This multicenter, randomized, placebo controlled trial investigated whether vitamin D₃ supplementation (4000 IU/day) could prevent …
This perspective piece reflects on the landmark approval of exagamglogene autotemcel (exa-cel) for sickle cell …
This article discusses emerging concerns about secondary T-cell cancers following treatment with chimeric antigen receptor …
This correspondence details a case study of a 29 year old man with WHIM like …
This phase 3 study evaluated exagamglogene autotemcel (exa-cel), a CRISPR Cas9 gene edited autologous cell …
This 52 week randomized, controlled trial evaluated the safety and efficacy of bempedoic acid in …
This phase 1 study evaluates NTLA 2002, a CRISPR Cas9 based in vivo gene-editing therapy …
A 57 year old woman with a history of depression and insomnia presented with severe …
This clinical case describes a 55-year-old woman with chronic joint pain and digital clubbing, ultimately …
This editorial reviews recent evidence on the management of subclinical atrial fibrillation (SCAF), particularly in …
A preterm male infant born at 31 weeks’ gestation via cesarean section for fetal distress …
